US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist

7.100
-0.100-1.39%

Close Aug 23 16:00 ET

132.43MMarket Cap-5503P/E (TTM)

Nuvectis Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-26.36%18.12M

25.83%19.46M

-4.34%19.13M

-6.69%22.06M

81.26%24.6M

-7.34%15.47M

248.19%19.99M

247.19%23.64M

-Cash and cash equivalents

-26.36%18.12M

25.83%19.46M

-4.34%19.13M

-6.69%22.06M

81.26%24.6M

-7.34%15.47M

248.19%19.99M

247.19%23.64M

Other current assets

-46.63%182K

-66.22%250K

-85.68%59K

-83.44%203K

-48.80%341K

-20.00%740K

352.75%412K

--1.23M

Total current assets

-26.63%18.3M

21.63%19.71M

-5.98%19.19M

-10.47%22.26M

75.17%24.94M

-8.00%16.21M

249.82%20.41M

265.19%24.87M

Non current assets

Non current deferred assets

----

--0

Total non current assets

--0

Total assets

-26.63%18.3M

21.63%19.71M

-5.98%19.19M

-10.47%22.26M

75.17%24.94M

-8.00%16.21M

206.52%20.41M

265.19%24.87M

Liabilities

Current liabilities

Payables

-16.17%1.85M

-16.08%1.76M

-17.53%2.77M

20.79%3.49M

24.06%2.2M

-7.67%2.1M

78.53%3.36M

484.04%2.89M

-accounts payable

2.38%1.85M

-16.08%1.76M

-4.78%2.77M

55.13%3.49M

25.73%1.8M

55.37%2.1M

175.05%2.91M

354.75%2.25M

-Other payable

----

17.01%399K

----

-45.39%450K

--640K

Current accrued expenses

-45.71%310K

211.54%486K

-6.74%415K

-78.59%158K

-27.72%571K

-77.62%156K

12.66%445K

--738K

Current liabilities

25.19%5.77M

44.69%5.69M

12.90%6.98M

24.13%5.58M

68.33%4.61M

28.60%3.93M

155.73%6.19M

807.47%4.49M

Non current liabilities

Preferred securities outside stock equity

----

--0

Total non current liabilities

--0

Total liabilities

25.19%5.77M

44.69%5.69M

12.90%6.98M

24.13%5.58M

68.33%4.61M

28.60%3.93M

-64.98%6.19M

-71.46%4.49M

Shareholders'equity

Share capital

--0

-common stock

--0

Retained earnings

-50.55%-62.84M

-62.11%-58.42M

-69.60%-54.25M

-88.32%-47.62M

-115.03%-41.74M

-127.44%-36.03M

-147.95%-31.99M

-137.70%-25.29M

Paid-in capital

21.42%75.37M

49.95%72.44M

43.81%66.45M

40.83%64.31M

100.81%62.07M

58.90%48.31M

2,342.07%46.2M

2,575.04%45.66M

Total stockholders'equity

-38.38%12.53M

14.24%14.02M

-14.19%12.2M

-18.10%16.69M

76.80%20.33M

-15.69%12.27M

229.17%14.22M

328.10%20.37M

Total equity

-38.38%12.53M

14.24%14.02M

-14.19%12.2M

-18.10%16.69M

76.80%20.33M

-15.69%12.27M

229.17%14.22M

328.10%20.37M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-26.36%18.12M	25.83%19.46M	-4.34%19.13M	-4.34%19.13M	-6.69%22.06M	81.26%24.6M	-7.34%15.47M	248.19%19.99M	248.19%19.99M	247.19%23.64M
-Cash and cash equivalents	-26.36%18.12M	25.83%19.46M	-4.34%19.13M	-4.34%19.13M	-6.69%22.06M	81.26%24.6M	-7.34%15.47M	248.19%19.99M	248.19%19.99M	247.19%23.64M
Other current assets	-46.63%182K	-66.22%250K	-85.68%59K	-85.68%59K	-83.44%203K	-48.80%341K	-20.00%740K	352.75%412K	352.75%412K	--1.23M
Total current assets	-26.63%18.3M	21.63%19.71M	-5.98%19.19M	-5.98%19.19M	-10.47%22.26M	75.17%24.94M	-8.00%16.21M	249.82%20.41M	249.82%20.41M	265.19%24.87M
Non current assets
Non current deferred assets	----	----	----	----	----	----	----	----	----	--0
Total non current assets	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	-26.63%18.3M	21.63%19.71M	-5.98%19.19M	-5.98%19.19M	-10.47%22.26M	75.17%24.94M	-8.00%16.21M	206.52%20.41M	206.52%20.41M	265.19%24.87M
Liabilities
Current liabilities
Payables	-16.17%1.85M	-16.08%1.76M	-17.53%2.77M	-17.53%2.77M	20.79%3.49M	24.06%2.2M	-7.67%2.1M	78.53%3.36M	78.53%3.36M	484.04%2.89M
-accounts payable	2.38%1.85M	-16.08%1.76M	-4.78%2.77M	-4.78%2.77M	55.13%3.49M	25.73%1.8M	55.37%2.1M	175.05%2.91M	175.05%2.91M	354.75%2.25M
-Other payable	----	----	----	----	----	17.01%399K	----	-45.39%450K	-45.39%450K	--640K
Current accrued expenses	-45.71%310K	211.54%486K	-6.74%415K	-6.74%415K	-78.59%158K	-27.72%571K	-77.62%156K	12.66%445K	12.66%445K	--738K
Current liabilities	25.19%5.77M	44.69%5.69M	12.90%6.98M	12.90%6.98M	24.13%5.58M	68.33%4.61M	28.60%3.93M	155.73%6.19M	155.73%6.19M	807.47%4.49M
Non current liabilities
Preferred securities outside stock equity	----	----	----	----	----	----	----	----	----	--0
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	25.19%5.77M	44.69%5.69M	12.90%6.98M	12.90%6.98M	24.13%5.58M	68.33%4.61M	28.60%3.93M	-64.98%6.19M	-64.98%6.19M	-71.46%4.49M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-50.55%-62.84M	-62.11%-58.42M	-69.60%-54.25M	-69.60%-54.25M	-88.32%-47.62M	-115.03%-41.74M	-127.44%-36.03M	-147.95%-31.99M	-147.95%-31.99M	-137.70%-25.29M
Paid-in capital	21.42%75.37M	49.95%72.44M	43.81%66.45M	43.81%66.45M	40.83%64.31M	100.81%62.07M	58.90%48.31M	2,342.07%46.2M	2,342.07%46.2M	2,575.04%45.66M
Total stockholders'equity	-38.38%12.53M	14.24%14.02M	-14.19%12.2M	-14.19%12.2M	-18.10%16.69M	76.80%20.33M	-15.69%12.27M	229.17%14.22M	229.17%14.22M	328.10%20.37M
Total equity	-38.38%12.53M	14.24%14.02M	-14.19%12.2M	-14.19%12.2M	-18.10%16.69M	76.80%20.33M	-15.69%12.27M	229.17%14.22M	229.17%14.22M	328.10%20.37M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall